{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:31:58Z","timestamp":1781908318028,"version":"3.54.5"},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The World Health Organization has set a goal of hepatitis C virus (HCV) elimination by the year 2030. However, no regions in Japan have succeeded in eradicating HCV. Micro-elimination is an approach to attain hepatitis C eradication in which national eradication goals are applied to specific populations so that viral treatment and control efforts can move forward quickly and efficiently. In order to eradicate HCV from Japan, this study aims to achieve HCV micro-elimination in the town of Nagawa.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods and design<\/jats:title>\n<jats:p>The Nagawa Project is an ongoing, prospective, multiple-institution, observational study running from April 1, 2021, to March 31, 2024. All residents of Nagawa town, excluding those under 20 years of age, not consenting to the study, or unable to undergo health check-ups due to nursing care needs, will be included. If found to be HCV antibody-positive, the participant will be recommended to see a doctor in consideration of MAC-2 binding protein glycosylation isomer values. Then, the participant will undergo serum HCV RNA measurement with the real-time polymerase chain reaction by an attending physician. If the participant is HCV RNA-positive, he or she will be referred to a hepatologist for further evaluation. In the case of a definitive diagnosis of chronic hepatitis C, direct acting antiviral treatment will be initiated. Through this process, HCV will be systematically micro-eliminated from the region.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Discussion<\/jats:title>\n<jats:p>The Nagawa Project will reveal the prevalence of chronic HCV in addition to the HCV eradication rate in Nagawa town towards achieving HCV micro-elimination.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Trial registration<\/jats:title>\n<jats:p>This study is performed by Shinshu University School of Medicine and was registered as UMIN 000044114 on May 6, 2021.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0256711","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T17:29:21Z","timestamp":1629998961000},"page":"e0256711","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Protocol: Prospective observational study aiming for micro-elimination of hepatitis C virus in Nagawa town: The Nagawa Project"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6313-5549","authenticated-orcid":true,"given":"Hiroyuki","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6364-9654","authenticated-orcid":true,"given":"Satoru","family":"Joshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Akahane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Aomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Joshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Midorikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Suyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6400-5658","authenticated-orcid":true,"given":"Masao","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-ichi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0162-4208","authenticated-orcid":true,"given":"Yuki","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-7628","authenticated-orcid":true,"given":"Ayumi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoo","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Misawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-919X","authenticated-orcid":true,"given":"Takeji","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"issue":"4","key":"pone.0256711.ref001","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.1840120409","article-title":"Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus","volume":"12","author":"K Kiyosawa","year":"1990","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"pone.0256711.ref002","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00535-018-1532-5","article-title":"A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011\u20132015 update","volume":"54","author":"R Tateishi","year":"2019","journal-title":"J Gastroenterol"},{"issue":"12","key":"pone.0256711.ref003","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1111\/jvh.12973","article-title":"Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals","volume":"25","author":"A Sugiura","year":"2018","journal-title":"J Viral Hepat"},{"issue":"4","key":"pone.0256711.ref004","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8040074","article-title":"Effectiveness of Glecaprevir\/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases","volume":"8","author":"A Sugiura","year":"2020","journal-title":"Biomedicines"},{"issue":"3","key":"pone.0256711.ref005","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/liv.14779","article-title":"Progress towards hepatitis C virus elimination in high-income countries: An updated analysis","volume":"41","author":"I Gamkrelidze","year":"2021","journal-title":"Liver Int"},{"issue":"3","key":"pone.0256711.ref006","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.14324","article-title":"Global timing of hepatitis C virus elimination in high-income countries","volume":"40","author":"H Razavi","year":"2020","journal-title":"Liver Int"},{"issue":"4","key":"pone.0256711.ref007","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jhep.2017.06.033","article-title":"Micro-elimination\u2014A path to global elimination of hepatitis C","volume":"67","author":"JV Lazarus","year":"2017","journal-title":"J Hepatol"},{"key":"pone.0256711.ref008","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/srep01065","article-title":"A serum \"sweet-doughnut\" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis","volume":"3","author":"A Kuno","year":"2013","journal-title":"Sci Rep"},{"issue":"2","key":"pone.0256711.ref009","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/hepr.12712","article-title":"Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection","volume":"47","author":"Y Ichikawa","year":"2017","journal-title":"Hepatol Res"},{"issue":"10","key":"pone.0256711.ref010","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/hepr.13361","article-title":"Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis","volume":"49","author":"S Joshita","year":"2019","journal-title":"Hepatol Res"},{"issue":"7","key":"pone.0256711.ref011","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/jgh.14929","article-title":"Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis","volume":"35","author":"S Joshita","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"pone.0256711.ref012","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ajg.2015.118","article-title":"Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis","volume":"110","author":"T Umemura","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"pone.0256711.ref013","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/hepr.12645","article-title":"JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2","volume":"46","author":"Y Asahina","year":"2016","journal-title":"Hepatology Research"},{"issue":"1","key":"pone.0256711.ref014","doi-asserted-by":"crossref","first-page":"11435","DOI":"10.1038\/s41598-020-68021-2","article-title":"A nationwide cross-sectional survey on hepatitis B and C screening among workers in Japan","volume":"10","author":"M Tatemichi","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0256711.ref015","article-title":"Use of the Serum Wisteria floribunda Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C Patients","volume":"10","author":"T Hayashi","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"50","key":"pone.0256711.ref016","doi-asserted-by":"crossref","first-page":"e18366","DOI":"10.1097\/MD.0000000000018366","article-title":"Combined albumin-bilirubin grade and Mac-2 binding protein glycosylation isomer as a useful predictor in compensated liver cirrhosis","volume":"98","author":"H Nishikawa","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"pone.0256711.ref017","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1111\/hepr.12466","article-title":"Wisteria floribunda agglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients","volume":"45","author":"N Tamaki","year":"2015","journal-title":"Hepatol Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0256711","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T17:29:38Z","timestamp":1629998978000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0256711"}},"subtitle":[],"editor":[{"given":"Wan-Long","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":17,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0256711","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]}}}